Literature DB >> 12110039

Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure.

A Peter Maxwell1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12110039     DOI： 10.1046/j.1523-1755.2002.00474.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  3 in total

1.  A randomized controlled study comparing once-weekly to every-2-week and every-4-week dosing of epoetin alfa in CKD patients with anemia.

Authors:  Pablo E Pergola; Gary Gartenberg; Min Fu; Steven Sun; Marsha Wolfson; Peter Bowers
Journal:  Clin J Am Soc Nephrol       Date:  2010-02-25       Impact factor: 8.237

2.  Renal anemia: a nephrologist's view.

Authors:  G Tsagalis
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

3.  A randomized controlled study of weekly and biweekly dosing of epoetin alfa in CKD Patients with anemia.

Authors:  Pablo E Pergola; Gary Gartenberg; Min Fu; Marsha Wolfson; Sudhakar Rao; Peter Bowers
Journal:  Clin J Am Soc Nephrol       Date:  2009-09-17       Impact factor: 8.237
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.